{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "scrolled": false
   },
   "outputs": [],
   "source": [
    "'''Extract plain text from pdf with pdfminer.six library'''\n",
    "\n",
    "from pdfminer.high_level import extract_text\n",
    "\n",
    "with open('/home/azashiro/Desktop/beetroot_task/task.pdf','rb') as file:\n",
    "    theses = extract_text(file)\n",
    "    t = \" \".join(theses.split())\n",
    "    text = \"\".join(t)\n",
    "    #print(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "'''Spliting extracted text with pattern'''\n",
    "\n",
    "import re\n",
    "\n",
    "pattern = re.compile(r\"(P\\d{3})\")\n",
    "text_list = []\n",
    "text_list = re.split(pattern, text)\n",
    "text_list.remove(text_list[0]) # remove page number\n",
    "#print(text_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "'''Converting splited list of the text in dictionary'''\n",
    "\n",
    "def Convert(a):\n",
    "    it = iter(a)\n",
    "    res_dct = dict(zip(it, it))\n",
    "    return res_dct\n",
    "\n",
    "text_dict = Convert(text_list)\n",
    "\n",
    "#print(text_dict)\n",
    "#print(type(text_dict)) # check type"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "'''Detach thesis index'''\n",
    "\n",
    "import re\n",
    "\n",
    "pattern = re.compile(r\"P\\d{3}\")\n",
    "filtered = [i for i in text_list if not pattern.match(i)]\n",
    "#print(filtered)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "'''Abstracts titles'''\n",
    "import re\n",
    "\n",
    "titles = re.compile(r\"\\w+[A-Z\\w+]\\w+.* (?=Introduction.*)|(?=Background.*)|(?=TNF therapy.*)\")\n",
    "abstract_title = [ m.group() for m in (titles.search(line) for line in filtered) if m]\n",
    "#abstract_title"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "'''Abstracts authors with location'''\n",
    "import re\n",
    "\n",
    "authors = re.compile(r\"\\w+[^A-Z\\d\\xad),.:;'?]\\s\\w.* (?=Introduction.*)|(?=Background.*)|(?=TNF therapy.*)\")\n",
    "auth_list = [ m.group() for m in (authors.search(line) for line in filtered) if m]\n",
    "\n",
    "list_a = [re.sub(r'[0-9]', '', i) for i in auth_list] # removing indexes from names\n",
    "name_list = [re.sub(r'\\w-\\s', '', i) for i in list_a] # removing hyphenations\n",
    "#name_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "'''Abstracts text'''\n",
    "thesis = re.compile(r\"(Introduction.*| Background.* | TNF therapy.*)\")\n",
    "thesis_list = [ m.group() for m in (thesis.search(line) for line in filtered) if m]\n",
    "abstract_text = [re.sub(r'\\w-\\s', '', i) for i in thesis_list] #removing indexes from text\n",
    "#abstract_text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>About the person</th>\n",
       "      <th>Session name</th>\n",
       "      <th>Topic title</th>\n",
       "      <th>Presentation abstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Zhu Shen Institute of Dermatology and Venereol...</td>\n",
       "      <td>P100</td>\n",
       "      <td>IMMUNOLOGICAL MEMORY EXISTS IN THE RECURRENT L...</td>\n",
       "      <td>Introduction: Psoriasis usually recurs in prev...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Samar Gupta, Alicja Wasilewski University of M...</td>\n",
       "      <td>P101</td>\n",
       "      <td>INVESTIGATING SYSTEMIC INFLAMMATION AS THE COM...</td>\n",
       "      <td>Introduction: Psychosocial factors are importa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Touraj Khosravi-Hafshejani, Mehran Ghoreishi, ...</td>\n",
       "      <td>P102</td>\n",
       "      <td>THE IMMUNE­PHENOTYPE OF SMALL PLAQUE PSORIASIS...</td>\n",
       "      <td>Introduction: Small plaque psoriasis (SPP) is ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Goksal Keskin, Ali Inal, Esra Dilek Keskin, Um...</td>\n",
       "      <td>P104</td>\n",
       "      <td>SERUM GLUCOCORTICOID­INDUCIBLE KINASE­ 1(SGK1)...</td>\n",
       "      <td>Introduction: Psoriatic arthritis (PsA) is an ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Akiko Arakawa, Emma Reeves, Sigrid Vollmer, Yu...</td>\n",
       "      <td>P105</td>\n",
       "      <td>DIFFERENTIAL NH2­TERMINAL AUTOANTIGEN TRIMMING...</td>\n",
       "      <td>Introduction: NH2-terminal trimming by endopla...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Secil Vural, Yukiyasu Arakawa, Adrian Galinski...</td>\n",
       "      <td>P106</td>\n",
       "      <td>ENVIRONMENTAL TRIGGERS OF AN HLA­C*06:02­ REST...</td>\n",
       "      <td>Introduction: Psoriasis vulgaris is a multifac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td></td>\n",
       "      <td>P107</td>\n",
       "      <td></td>\n",
       "      <td>Background: Psoriasis lesions evolve as a res...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Omid Zargari, Ehsan Kazemnejad, Seyyede Zeinab...</td>\n",
       "      <td>P108</td>\n",
       "      <td>NAIL INVOLVEMENT IN PSORIASIS; IS IT A PREDICT...</td>\n",
       "      <td>Introduction: Psoriatic Arthritis (PsA) arises...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Kim Papp, Remus Ioan Orasan, Paula Polzer, Car...</td>\n",
       "      <td>P109</td>\n",
       "      <td>ABSOLUTE AND RELATIVE PASI IMPROVEMENTS WITH I...</td>\n",
       "      <td>Introduction and Objectives: Ixekizumab (IXE),...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td></td>\n",
       "      <td>P110</td>\n",
       "      <td></td>\n",
       "      <td>Background: Prevalence of psoriatic arthritis...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Elena Gubar, Elena Loginova, Svetlana Glukhova...</td>\n",
       "      <td>P111</td>\n",
       "      <td>SKIN LESION SEVERITY IN EARLY AXIAL AND PERIPH...</td>\n",
       "      <td>Introduction: Comparative analysis of skin les...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td></td>\n",
       "      <td>P112</td>\n",
       "      <td></td>\n",
       "      <td>Background/Objective:Patients with moderate-t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Christopher Griffiths, A. Blauvelt, K. Reich, ...</td>\n",
       "      <td>P113</td>\n",
       "      <td>SECUKINUMAB’S LONG­TERM SAFETY REMAINS FAVORAB...</td>\n",
       "      <td>Introduction and Objectives: Psoriasis is a co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Arthur Kavanaugh, Alice Gottlieb, Akimichi Mor...</td>\n",
       "      <td>P114</td>\n",
       "      <td>IMPACT OF IMPROVEMENT IN SKIN AND JOINT ON QUA...</td>\n",
       "      <td>Introduction: Psoriatic arthritis (PsA) is a c...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Alice B Gottlieb, John Sullivan, Alexey Kubano...</td>\n",
       "      <td>P115</td>\n",
       "      <td>SECUKINUMAB SHOWS HIGH AND SUSTAINED EFFICACY ...</td>\n",
       "      <td>Introduction: Palmoplantar psoriasis (ppPsO) o...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Kristian Reich, Petr Arenberger, Ulrich Mrowie...</td>\n",
       "      <td>P116</td>\n",
       "      <td>SECUKINUMAB SHOWS HIGH AND SUSTAINED EFFICACY ...</td>\n",
       "      <td>Introduction: Nail psoriasis is associated wit...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td></td>\n",
       "      <td>P117</td>\n",
       "      <td></td>\n",
       "      <td>Background: Psoriasis (PsO) is a chronic infl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Kim Papp, Melinda Gooderham, Jennifer Beecker,...</td>\n",
       "      <td>P118</td>\n",
       "      <td>DIAGNOSIS OF PSORIATIC ARTHRITIS IN PATIENTS W...</td>\n",
       "      <td>Introduction: Secukinumab (SEC) is a fully hum...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Wolf Henning Boehncke, Alice Gottlieb, Atul De...</td>\n",
       "      <td>P119</td>\n",
       "      <td>EFFICACY AND SAFETY RESULTS OF GUSELKUMAB IN P...</td>\n",
       "      <td>Introduction/Objective:To evaluate the efficac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Andrew Blauvelt, Howard Sofen, Kim Papp, Melin...</td>\n",
       "      <td>P120</td>\n",
       "      <td>TILDRAKIZUMAB EFFICACY OVER TIME BY WEEK 28 RE...</td>\n",
       "      <td>Introduction: Tildrakizumab (TIL), a humanized...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Lynn Price, Jennifer Robinson, Gianna Melendez...</td>\n",
       "      <td>P122</td>\n",
       "      <td>POTENTIAL DISCONNECT: CO­MANAGEMENT OF PATIENT...</td>\n",
       "      <td>Introduction: On average, the majority of psor...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td></td>\n",
       "      <td>P123</td>\n",
       "      <td></td>\n",
       "      <td>TNF therapy has been the standard of care for...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Luis Puig, Chenglong Han, Ron Vender, Michael ...</td>\n",
       "      <td>P124</td>\n",
       "      <td>IMPACT OF GUSELKUMAB VERSUS PLACEBO AND ADALIM...</td>\n",
       "      <td>Introduction/Objective:VOYAGE 2 is a phase 3 d...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     About the person Session name  \\\n",
       "0   Zhu Shen Institute of Dermatology and Venereol...         P100   \n",
       "1   Samar Gupta, Alicja Wasilewski University of M...         P101   \n",
       "2   Touraj Khosravi-Hafshejani, Mehran Ghoreishi, ...         P102   \n",
       "3   Goksal Keskin, Ali Inal, Esra Dilek Keskin, Um...         P104   \n",
       "4   Akiko Arakawa, Emma Reeves, Sigrid Vollmer, Yu...         P105   \n",
       "5   Secil Vural, Yukiyasu Arakawa, Adrian Galinski...         P106   \n",
       "6                                                             P107   \n",
       "7   Omid Zargari, Ehsan Kazemnejad, Seyyede Zeinab...         P108   \n",
       "8   Kim Papp, Remus Ioan Orasan, Paula Polzer, Car...         P109   \n",
       "9                                                             P110   \n",
       "10  Elena Gubar, Elena Loginova, Svetlana Glukhova...         P111   \n",
       "11                                                            P112   \n",
       "12  Christopher Griffiths, A. Blauvelt, K. Reich, ...         P113   \n",
       "13  Arthur Kavanaugh, Alice Gottlieb, Akimichi Mor...         P114   \n",
       "14  Alice B Gottlieb, John Sullivan, Alexey Kubano...         P115   \n",
       "15  Kristian Reich, Petr Arenberger, Ulrich Mrowie...         P116   \n",
       "16                                                            P117   \n",
       "17  Kim Papp, Melinda Gooderham, Jennifer Beecker,...         P118   \n",
       "18  Wolf Henning Boehncke, Alice Gottlieb, Atul De...         P119   \n",
       "19  Andrew Blauvelt, Howard Sofen, Kim Papp, Melin...         P120   \n",
       "20  Lynn Price, Jennifer Robinson, Gianna Melendez...         P122   \n",
       "21                                                            P123   \n",
       "22  Luis Puig, Chenglong Han, Ron Vender, Michael ...         P124   \n",
       "\n",
       "                                          Topic title  \\\n",
       "0   IMMUNOLOGICAL MEMORY EXISTS IN THE RECURRENT L...   \n",
       "1   INVESTIGATING SYSTEMIC INFLAMMATION AS THE COM...   \n",
       "2   THE IMMUNE­PHENOTYPE OF SMALL PLAQUE PSORIASIS...   \n",
       "3   SERUM GLUCOCORTICOID­INDUCIBLE KINASE­ 1(SGK1)...   \n",
       "4   DIFFERENTIAL NH2­TERMINAL AUTOANTIGEN TRIMMING...   \n",
       "5   ENVIRONMENTAL TRIGGERS OF AN HLA­C*06:02­ REST...   \n",
       "6                                                       \n",
       "7   NAIL INVOLVEMENT IN PSORIASIS; IS IT A PREDICT...   \n",
       "8   ABSOLUTE AND RELATIVE PASI IMPROVEMENTS WITH I...   \n",
       "9                                                       \n",
       "10  SKIN LESION SEVERITY IN EARLY AXIAL AND PERIPH...   \n",
       "11                                                      \n",
       "12  SECUKINUMAB’S LONG­TERM SAFETY REMAINS FAVORAB...   \n",
       "13  IMPACT OF IMPROVEMENT IN SKIN AND JOINT ON QUA...   \n",
       "14  SECUKINUMAB SHOWS HIGH AND SUSTAINED EFFICACY ...   \n",
       "15  SECUKINUMAB SHOWS HIGH AND SUSTAINED EFFICACY ...   \n",
       "16                                                      \n",
       "17  DIAGNOSIS OF PSORIATIC ARTHRITIS IN PATIENTS W...   \n",
       "18  EFFICACY AND SAFETY RESULTS OF GUSELKUMAB IN P...   \n",
       "19  TILDRAKIZUMAB EFFICACY OVER TIME BY WEEK 28 RE...   \n",
       "20  POTENTIAL DISCONNECT: CO­MANAGEMENT OF PATIENT...   \n",
       "21                                                      \n",
       "22  IMPACT OF GUSELKUMAB VERSUS PLACEBO AND ADALIM...   \n",
       "\n",
       "                                Presentation abstract  \n",
       "0   Introduction: Psoriasis usually recurs in prev...  \n",
       "1   Introduction: Psychosocial factors are importa...  \n",
       "2   Introduction: Small plaque psoriasis (SPP) is ...  \n",
       "3   Introduction: Psoriatic arthritis (PsA) is an ...  \n",
       "4   Introduction: NH2-terminal trimming by endopla...  \n",
       "5   Introduction: Psoriasis vulgaris is a multifac...  \n",
       "6    Background: Psoriasis lesions evolve as a res...  \n",
       "7   Introduction: Psoriatic Arthritis (PsA) arises...  \n",
       "8   Introduction and Objectives: Ixekizumab (IXE),...  \n",
       "9    Background: Prevalence of psoriatic arthritis...  \n",
       "10  Introduction: Comparative analysis of skin les...  \n",
       "11   Background/Objective:Patients with moderate-t...  \n",
       "12  Introduction and Objectives: Psoriasis is a co...  \n",
       "13  Introduction: Psoriatic arthritis (PsA) is a c...  \n",
       "14  Introduction: Palmoplantar psoriasis (ppPsO) o...  \n",
       "15  Introduction: Nail psoriasis is associated wit...  \n",
       "16   Background: Psoriasis (PsO) is a chronic infl...  \n",
       "17  Introduction: Secukinumab (SEC) is a fully hum...  \n",
       "18  Introduction/Objective:To evaluate the efficac...  \n",
       "19  Introduction: Tildrakizumab (TIL), a humanized...  \n",
       "20  Introduction: On average, the majority of psor...  \n",
       "21   TNF therapy has been the standard of care for...  \n",
       "22  Introduction/Objective:VOYAGE 2 is a phase 3 d...  "
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "'''Grouping patterns with pandas library'''\n",
    "import pandas as pd\n",
    "df = pd.DataFrame({\"About the person\": name_list,\n",
    "                   \"Session name\": text_dict.keys(),\n",
    "                   \"Topic title\": abstract_title,\n",
    "                   \"About the person\": name_list,\n",
    "                   \"Presentation abstract\": abstract_text})\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "'''Import pandas DataFrame into Excel file'''\n",
    "\n",
    "excel_file = df.to_excel(\"/home/azashiro/Desktop/beetroot_task/Data.xlsx\")\n",
    "excel_file"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
